1. Home
  2. TKLF vs CLGN Comparison

TKLF vs CLGN Comparison

Compare TKLF & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yoshitsu Co. Ltd

TKLF

Yoshitsu Co. Ltd

HOLD

Current Price

$2.94

Market Cap

15.6M

ML Signal

HOLD

Logo CollPlant Biotechnologies Ltd

CLGN

CollPlant Biotechnologies Ltd

HOLD

Current Price

$0.69

Market Cap

18.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TKLF
CLGN
Founded
2006
2004
Country
Japan
Israel
Employees
N/A
N/A
Industry
Other Specialty Stores
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.6M
18.4M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
TKLF
CLGN
Price
$2.94
$0.69
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$11.00
AVG Volume (30 Days)
7.8K
114.3K
Earning Date
12-19-2025
03-25-2026
Dividend Yield
8.19%
N/A
EPS Growth
N/A
N/A
EPS
1.05
N/A
Revenue
$302,537,158.00
$2,475,000.00
Revenue This Year
N/A
$1,596.12
Revenue Next Year
N/A
$85.83
P/E Ratio
$2.88
N/A
Revenue Growth
37.82
280.77
52 Week Low
$2.10
$0.59
52 Week High
$4.32
$4.98

Technical Indicators

Market Signals
Indicator
TKLF
CLGN
Relative Strength Index (RSI) 45.73 26.39
Support Level $2.28 $0.66
Resistance Level $3.19 $1.99
Average True Range (ATR) 0.28 0.14
MACD -0.04 -0.10
Stochastic Oscillator 54.39 6.52

Price Performance

Historical Comparison
TKLF
CLGN

About TKLF Yoshitsu Co. Ltd

Tokyo Lifestyle Co Ltd, formerly Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores, Online Stores and Services, and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from Hong Kong, followed by Japan, the United States, and other overseas markets.

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.

Share on Social Networks: